Hepion Pharmaceuticals (HEPA) Institutional Ownership $0.48 -0.13 (-21.31%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.46 -0.02 (-3.12%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Hepion Pharmaceuticals (NASDAQ:HEPA)CurrentInstitutional OwnershipPercentage17.24%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$14.19MNumber ofInstitutional Sellers(last 12 months)0 Get HEPA Insider Trade Alerts Want to know when executives and insiders are buying or selling Hepion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HEPA Institutional Buying and Selling by Quarter Remove Ads Hepion Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Anson Funds Management LP231,849$155K0.0%N/A3.331% 8/15/2024 Armistice Capital LLC516,000$526K0.0%+32.3%9.428% 2/13/2024 Armistice Capital LLC418,000$1.35M0.0%+5.1%9.631% 11/15/2023 Armistice Capital LLC397,607$1.98M0.0%N/A10.360% 5/1/2023 Virtu Financial LLC53,501$42K0.0%+152.8%0.070% 11/7/2022 Virtu Financial LLC67,802$34K0.0%+195.6%0.089% 10/13/2022 PVG Asset Management Corp107,915$55K0.2%N/A0.142% 8/12/2022 Ikarian Capital LLC410,189$235K0.0%-29.5%0.538% 2/4/2022 Envestnet Asset Management Inc.72,027$82K0.0%+87.5%0.094% 2/2/2022 PVG Asset Management Corp100,089$114K0.4%+92.5%0.131% Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/10/2021 PVG Asset Management Corp51,989$80K0.2%-72.6%0.068% 11/9/2021BlackRock Inc.1,634,012$2.50M0.0%-1.0%2.144% 11/5/2021 PNC Financial Services Group Inc.39,034$60K0.0%N/A0.051% 10/13/2021Asset Management Corp IL ADV133,500$204K0.1%+45.9%0.175% 9/17/2021 Virtu Financial LLC113,869$225K0.0%-36.4%0.149% 8/18/2021 Ikarian Capital LLC1,365,059$2.70M0.2%N/A1.791% 8/17/2021 PVG Asset Management Corp189,616$375K1.2%+1,241.0%0.249% 8/17/2021 Boothbay Fund Management LLC155,069$307K0.0%N/A0.203% 8/16/2021 Morgan Stanley91,106$180K0.0%+197,956.5%0.120% 8/16/2021 State Street Corp322,716$639K0.0%N/A0.423% 8/16/2021 Goldman Sachs Group Inc.68,399$135K0.0%N/A0.090% 8/13/2021 Altium Capital Management LP446,000$883K0.2%N/A0.585% 8/13/2021 Geode Capital Management LLC651,318$1.29M0.0%+10.6%0.854% 8/11/2021BlackRock Inc.1,649,929$3.27M0.0%-3.9%2.165% 8/6/2021Asset Management Corp IL ADV91,500$181K0.1%N/A0.120% 8/4/2021 Envestnet Asset Management Inc.92,919$184K0.0%+256.9%0.122% 8/2/2021 Advisor Group Holdings Inc.17,751$35K0.0%+94.9%0.023% 8/2/2021 McAdam LLC55,978$86K0.0%+52.8%0.073% 5/19/2021 Virtu Financial LLC179,030$329K0.0%N/A0.235% 5/14/2021 PVG Asset Management Corp14,140$26K0.1%N/A0.019% 5/13/2021 Renaissance Technologies LLC157,500$290K0.0%-52.1%0.207% 5/13/2021 Bank of New York Mellon Corp48,602$89K0.0%+18.7%0.064% 5/12/2021 Northern Trust Corp145,515$268K0.0%+129.5%0.191% 5/12/2021 Geode Capital Management LLC588,718$1.08M0.0%+190.6%0.772% 5/12/2021 UBS Group AG68,202$125K0.0%+10,794.9%0.089% 5/11/2021 Rockefeller Capital Management L.P.20,000$36K0.0%N/A0.026% 5/10/2021 GSA Capital Partners LLP160,775$296K0.0%+80.5%0.211% 5/7/2021BlackRock Inc.1,716,168$3.16M0.0%+43.7%2.251% 5/6/2021 Prospera Financial Services Inc31,300$58K0.0%-20.4%0.041% 5/6/2021 Meitav Dash Investments Ltd.44,000$81K0.0%N/A0.058% DOGE could send 6 AI stocks through the roof (Ad)Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement from Elon any day now … Thousands of government jobs could be replaced … By a new form of AI. Recently perfected by Musk and his team at xAI.Click here to find out what DOGE's next move is.5/4/2021 Envestnet Asset Management Inc.26,037$48K0.0%N/A0.034% 4/28/2021 JGP Wealth Management LLC15,000$28K0.0%N/A0.020% 4/26/2021 McAdam LLC36,641$67K0.0%N/A0.048% 2/16/2021 Squarepoint Ops LLC111,978$245K0.0%+621.3%1.241% 2/11/2021 Northern Trust Corp63,402$139K0.0%N/A0.703% 2/10/2021 Renaissance Technologies LLC329,022$721K0.0%N/A3.646% 2/9/2021 Bank of New York Mellon Corp40,945$90K0.0%N/A0.454% 2/5/2021BlackRock Inc.1,194,434$2.62M0.0%+1,867.1%13.235% (Data available from 1/1/2016 forward)Remove Ads HEPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HEPA shares? During the previous two years, the following institutional investors and hedge funds held shares of Hepion Pharmaceuticals shares: Armistice Capital LLC ($526K), and Anson Funds Management LP ($155K), Virtu Financial LLC ($42K).Learn more on HEPA's institutional investors. What percentage of Hepion Pharmaceuticals stock is owned by institutional investors? 17.24% of Hepion Pharmaceuticals stock is owned by institutional investors. Learn more on HEPA's institutional investor holdings. Which institutional investors have been buying Hepion Pharmaceuticals stock? The following institutional investors have purchased Hepion Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($544K), Anson Funds Management LP ($231.85K), and Virtu Financial LLC ($32.34K). How much institutional buying is happening at Hepion Pharmaceuticals? Institutional investors have bought a total of 808,185 shares in the last 24 months. This purchase volume represents approximately $141.81M in transactions. Related Companies TFFP Major Shareholders SMFL Major Shareholders EFTR Major Shareholders This page (NASDAQ:HEPA) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hepion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
